ribbon.news
Updated Thursday, September 17, 2026, 17:04 ET · 41 sources
Study shows 84.4% clinical benefit with ivermectin and mebendazole...
1 outlethealth·Breitbart
As the outlets wrote it
- Breitbart: Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients
From the Thursday, September 17, 2026 edition · archive